Schedule 13D ownership disclosure
STEREOTAXIS INC
Common Stock, par value $0.001 per share · CUSIP: 85916J409
Event date: 2026-11-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- DAFNA Capital Management, LLCReported CIK 0001389933
Shares: 15,333,446.00 · Class: 15.1%
- Dr. Nathan FischelReported CIK 0001389932
Shares: 15,628,395.00 · Class: 15.3%
- Dr. Fariba GhodsianReported CIK 0001733969
Shares: 15,333,446.00 · Class: 15.1%
- DAFNA LifeScience, L.P.
Shares: 8,005,938.00 · Class: 7.9%
- DAFNA LifeScience Select, L.P.
Shares: 7,327,508.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-126321
- Form type
- SCHEDULE 13D/A
- Filer
- DAFNA Capital Management LLC
- CIK
- CIK 1389933
- Filed
- Nov 12, 2026
- Reporting period
- Nov 09, 2026
- Description
- Schedule 13D beneficial ownership